Results - Announcements
Sai Parenterals Ltd share price declined 7.74% to Rs 480.65. The Company's net profit jumped 32.70% to Rs 10.51 crore, while revenue from operations improved marginally 9.09% to Rs 194.92 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.72 lakh crore, rising 4.75%. It has improved by 2.16% over last one week and gained upto 0.86% in last one month while the market capitalization of Sai Parenterals Ltd has inched up 0.43% and 7.29% in the same period respectively.
Profit before tax (PBT) of Sai Parenterals Ltd stood at Rs 9.89 crore in Q3 FY26, gaining 8.09% year-on-year, and easing 1.02% quarter-on-quarter. EBITDA came in at Rs 37 crore, surging by 261.94% YoY and jumping 84.63% sequentially.
Total expenses increased by 10.11% to Rs 179.77 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 82.24 crore, tumbling by 29.18% YoY, while employee benefits expense was at Rs 12.86 crore, rising by 11.44% YoY.
For the TTM ended FY26, revenue from operations jumped by 133.58% to Rs 381.0 crore, while net profit slipped by 1.18% to Rs 14.26 crore, compared to previous TTM. EBITDA soared by 4639% to Rs 30.18 crore, and PBT plunged by 40.08% to Rs 11.93 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 93.05 crore in FY26, as against Rs 33.15 crore in FY25.
Sai Parenterals Ltd rallied 18.27% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 9.87% during the same period.
